Menactra meningococcal vaccine solution for injection 1 dose 0.5 ml No. 1

Menactra is a vaccine for the prevention of meningococcal disease. The vaccine is indicated for active immunization against meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals 9 months to 55 years of age. Menactra® does not prevent disease caused by N. meningitidis serogroup B.

Warehouse

One immunizing dose of the vaccine (0.5 ml) contains:

active ingredients:

* The amount of diphtheria toxoid is approximate and depends on the ratio of conjugated polysaccharide to protein.

excipients: sodium chloride; sodium hydrogen phosphate; sodium dihydrogen phosphate, monohydrate.

Contraindication

Severe allergic reaction (e.g. anaphylaxis) after a previous dose of a vaccine containing meningococcal capsular polysaccharide, diphtheria toxoid or CRM197 (diphtheria toxoid carrier protein), or to any component of Menactra® vaccine.

Method of application

The vaccine should be inspected visually for foreign matter or discoloration prior to administration. The vaccine should not be used if any of these conditions are present.

Menactra® vaccine is administered as a single dose of 0.5 ml intramuscularly.

Application features

Weakened immune response.

Some individuals with altered immunoreactivity, including individuals receiving immunosuppressive therapy, may have a reduced immune response to Menactra® vaccine.

Pregnant women

Only on doctor's prescription. Possible use considering benefit/risk.

Children

Menactra® vaccine is indicated for use from 9 months of age.

Drivers

No studies have been conducted on the effects on the ability to drive or use machines.

Overdose

Not detected.

Side effects

Because clinical trials are conducted under widely varying conditions, the incidence of adverse reactions to the administration of a vaccine observed during clinical trials cannot be directly compared to the incidence of reactions to the administration of a vaccine in clinical trials of other vaccines and may not reflect the incidence of reactions observed in clinical practice.

Storage conditions

Store at 2 to 8°C (in a refrigerator). Do not freeze.